Amryt Pharma Share Discussion Threads

[chica1] 15/9/2019 13:07

I dont know much about investing but I thought investing was for the long term.I've little or no clue what a CVR but if we get it great, if not so what. I have read that the AIM stock exchange is the wild west and to stay a mile away but I was told when AMYT gets on the Nasdaq and if management do their job property American investors reward the company appropriately.Did'nt the CEO at some stage say he wanted to create another Shire Pharmaceuticals? Both of you are SO ANNOYING!

[papillon] 14/9/2019 23:50

I've NEVER said I'm a shareholder, MADLOSS. What I've said is I hold my shares via an online broker nominee a/c. So as far as AMYT are concerned I don't exist! Hence I haven't received a shareholder pack. All that information is on the AMYT web site anyway. I just can't be bothered, or have the time, to read it. You, as a resident of Broadmoor, probably do have the time and the inclination! I go solely by the official RNS's. You can believe what you want, MADLOSS. It makes no odds to me what you believe. I'm just happy to be showing a profit. You're a conspiracy theorist, MADLOSS. You probably think that the Moon landing 50 years ago never happened and that the Earth is flat. You're not worth arguing with. This is the last time I will respond to your lunacy. I know I hold my AMYT shares in an online broker nominee a/c. Whether you believe that, or not, I just don't give a toss. Now be a good boy and let the nurses put your straightjcket back on.

[papillon] 14/9/2019 11:50

I must admit to being curious as to what mdalos was posting so I had a quick peek at his latest post. It's hilarious. I ROFLMAO! I think he's having trouble with his Caps Lock! He's obviously as mad as a hatter. I think his carers must remove his straitjacket now and again to enable him to post his very entertaining diatribes. I think they are a lot more liberal at Broadmoor these days and allow patients a chance to express themselves. PMSL. Do read his latest post as it's hilarious, but be very quick because he will soon delete it. I honestly believe that no one will take any notice of what mdalos posts, not even the very gullible. It's always interesting to read all viewpoints, but he stays on my filter because he seems to have some sort of personal vendetta against me. I don't know why; perhaps only the doctors treating him know the reason. LOL. PS I'm thinking of contacting the company and Nomad to enquire about the actual number of CVR's that will be in issue and whether they realise that some nutty poster on the ADVFN bb is posting that the facts contained in the RNS dated 27th August are lies and fake news. Perhaps that's why mdalos deletes all his posts. However one can NEVER delete your posts from ADVFN. They are still available if one knows where to look.

[papillon] 14/9/2019 11:33

Some (or someone) have (has) been loading up in a big way on Thursday. There were 9 big trades on Thursday where reporting was delayed that were only reported yesterday after the market closed!! From 40k all the way up to 175k shares (£44.8k up to £199.62k). Going by the prices and times the trades were completed it looks like they are a mixture of buys and sells, but going by the share price rises on Thursday and yesterday I'm pretty certain the buys outnumber the sells. Many thanks, Bermudashorts, for posting that link to the youtube video of Cathal Friel's very positive verdict on the Aegerion acquisition/RTO. He was rather fulsome in his praise for Joe Wiley and Rory Nealon on negotiating the deal. He was obviously very impressed with the way they have turned AMYT from a company whose share price was very dependent on the success, or otherwise, on a single product, AP101 into a broad based biopharma with sales of over US$130m pa whose share price wont collapse if AP101 fails the Phase III trial. I wonder if Friel was topping up on Thursday? It wouldn't surprise me. PS. I remember Amicus's share price DIDN'T collapse when Zorblisa (Socioderm's treatment for EB that was acquired by Amicus in an extremely generous deal for Socioderm shareholders) was ditched by Amicus when it was deemed to to be a failure at the interim stage of it's Phase III trial. In fact the Amicus share price hardly moved. Perhaps that was because investors felt the Amicus deal had been far too generous for Socioderm shareholders. Hopefully something similar could be the case for the AMYT share price if AP101 fails it's Phase III trial. Of course the deal for old AMYT shareholders (pre the completion of the Aegerion deal) is nowhere near as generous as that offered by Amicus to Socioderm shareholders.

[digadee] 13/9/2019 17:01

Mdalos, why "chance your arm", sell up and move on. You have never liked this stock, why hang about, your in the black so sell and forget about all your amryt worries.

[richpassi] 13/9/2019 16:27

Cheers Pap I wouldn't split hairs on a difference of 4,000,000 shares ! Lol its all pie in the sky until it happens ;) Enjoy the weather and weekend :)

[papillon] 13/9/2019 15:25

Cathal Friel still has around 4,116,224 shares (via his Raglan Road vehicle) in AMYT (after taking into a/c the 1 for 6 consolidation. From the AMYT web site). He has hung onto them. At the moment they are worth around £5m to him. He'll also have 4,116,224 CVR's which could be worth up to another circa £5m to him in future IF all the milestones for AP101 are achieved. Not to be sniffed at, even for someone as rich as Cathal Friel.

[bermudashorts] 13/9/2019 15:09

ali47fish - this morning I believe

[alphabravo321] 13/9/2019 15:00

Cathal says Nasdaq plan for November

[ali47fish] 13/9/2019 14:55

when is this dated bermuda please no date with the video?

[bermudashorts] 13/9/2019 14:14

Not sure whether this has already been posted but Cathal Friel gives his views on the Aegerion deal in the Proactive interview below:- Https://www.youtube.com/watch?v=ZqelBgsW39I

[papillon] 13/9/2019 12:46

richpassi. Re my reply to you yesterday (post 4835). I made a very silly arithmetical error in the post. I stated that the maximum value of the CVR's (if AP101 passed all it's milestones) was £1.60 when it fact the RNS dated 27th August states CATEGORICALLY that the maximum pay out is US$1.48 (equivalent to £1.22 with an exchange rate of US$1 = £1.21) If one divides the maximum amount available to the CVR holders, US85m, by US$1.48 one gets the number of CVR's in existence by the cut off date of 20th September. That gives the number of CVR's as 57.432m NOT the 53.149m I have used in my post 4835. Apologies, richpassi, for my mistakes in post 4835. Hope you agree with my corrected figures. ATB

[papillon] 13/9/2019 11:06

Looks like you can sell above the mid price today, which is unusual for AMYT. Indicates demand for the shares?

[papillon] 13/9/2019 10:55

ali47fish. There is, as alphabravo states, a US$60m share placing @ 148p per share on the 24th September. If you buy AMYT shares before the cut off date of 20th September and keep them until after 20th September, as dim2602 states, you will be entitled to the CVR's. Whether the AMYT share price will drop after the 20th September, as dim2602 states, is open to question. That would normally be the case, but will it happen in this case bearing in mind that there is a £1.48 share placing just 4 days after and a fund manager like Mark Taub (see my post yesterday containing a link to his article) believes AMYT will be vastly undervalued compared with it's peer group on Nasdaq (AMYT intends to list on Nasdaq within 90 days of the Aegerion acquisition/RTO). Mark Taub was valuing AMYT (after it acquires Aegerion following the completion of the the RTO) almost solely on the circa US$136m sales revenue of the new AMYT, so how much value is being ascribed by investors to the CVR's (which could end up worthless) who can tell? Personally I believe dim2602 is correct and we could see a small, temporary, pull back in the share price after the 20th September, but it's by no means certain.